116 related articles for article (PubMed ID: 2111678)
1. [Cellular mechanisms of pulmonary vasoconstriction in an experimental model of protamine reversal of heparin].
Montalescot G
Arch Mal Coeur Vaiss; 1990 Apr; 83(4):555-60. PubMed ID: 2111678
[TBL] [Abstract][Full Text] [Related]
2. Imaging the ovine heparin-protamine interaction with 111In-protamine.
Montalescot G; Fischman AJ; Strauss HW; Wilkinson RA; Ahmad M; Fitzgibbon C; Robinson DW; Zapol WM
J Appl Physiol (1985); 1993 Aug; 75(2):963-71. PubMed ID: 8226502
[TBL] [Abstract][Full Text] [Related]
3. Platelet factor 4 injection produces acute pulmonary hypertension in the awake lamb.
Kurrek MM; Winkler M; Robinson DR; Zapol WM
Anesthesiology; 1995 Jan; 82(1):183-7; discussion 31A. PubMed ID: 7832299
[TBL] [Abstract][Full Text] [Related]
4. [Pulmonary reaction after protamine reversal of heparin in goats and rabbits].
Horiguchi T; Enzan K; Mitsuhata H; Murata M; Suzuki M
Masui; 1992 Aug; 41(8):1260-6. PubMed ID: 1433847
[TBL] [Abstract][Full Text] [Related]
5. Neutralization of low molecular weight heparin by polybrene prevents thromboxane release and severe pulmonary hypertension in awake sheep.
Montalescot G; Zapol WM; Carvalho A; Robinson DR; Torres A; Lowenstein E
Circulation; 1990 Nov; 82(5):1754-64. PubMed ID: 2171807
[TBL] [Abstract][Full Text] [Related]
6. Effect of platelet depletion on lung vasoconstriction in heparin-protamine reactions.
Montalescot G; Kreil E; Lynch K; Greene EM; Torres A; Carvalho A; Fitzgibbon C; Robinson DR; Lowenstein E; Zapol WM
J Appl Physiol (1985); 1989 May; 66(5):2344-50. PubMed ID: 2745299
[TBL] [Abstract][Full Text] [Related]
7. Heparin-protamine complexes cause pulmonary hypertension in goats.
Horiguchi T; Enzan K; Mitsuhata H; Murata M; Suzuki M
Anesthesiology; 1995 Oct; 83(4):786-91. PubMed ID: 7574058
[TBL] [Abstract][Full Text] [Related]
8. Adverse cardiopulmonary effects and increased plasma thromboxane concentrations following the neutralization of heparin with protamine in awake sheep are infusion rate-dependent.
Morel DR; Costabella PM; Pittet JF
Anesthesiology; 1990 Sep; 73(3):415-24. PubMed ID: 2098007
[TBL] [Abstract][Full Text] [Related]
9. Protamine-induced pulmonary hypertension in heparinized monkeys and pigs is inhibited by the thromboxane receptor antagonist SQ 30,741.
Schumacher WA; Heran CL; Ogletree ML
Eicosanoids; 1990; 3(2):87-93. PubMed ID: 2144979
[TBL] [Abstract][Full Text] [Related]
10. Thromboxane mediation of pulmonary hemodynamic responses after neutralization of heparin by protamine in pigs.
Conzen PF; Habazettl H; Gutmann R; Hobbhahn J; Goetz AE; Peter K; Brendel W
Anesth Analg; 1989 Jan; 68(1):25-31. PubMed ID: 2910134
[TBL] [Abstract][Full Text] [Related]
11. [Protamine and pulmonary hypertension].
Horiguchi T; Enzan K; Suzuki M
Kokyu To Junkan; 1992 Jan; 40(1):43-8. PubMed ID: 1557557
[No Abstract] [Full Text] [Related]
12. Thromboxane receptor blockade prevents pulmonary hypertension induced by heparin-protamine reactions in awake sheep.
Montalescot G; Lowenstein E; Ogletree ML; Greene EM; Robinson DR; Hartl K; Zapol WM
Circulation; 1990 Nov; 82(5):1765-77. PubMed ID: 2146041
[TBL] [Abstract][Full Text] [Related]
13. Acute pulmonary vasoconstriction and thromboxane release during protamine reversal of heparin anticoagulation in awake sheep. Evidence for the role of reactive oxygen metabolites following nonimmunological complement activation.
Morel DR; Lowenstein E; Nguyenduy T; Robinson DR; Repine JE; Chenoweth DE; Zapol WM
Circ Res; 1988 May; 62(5):905-15. PubMed ID: 3129208
[TBL] [Abstract][Full Text] [Related]
14. Involvement of fibrinogen in protamine-induced pulmonary hypertension.
Sogawa M; Mohammad SF
J Surg Res; 1997 Nov; 73(1):80-4. PubMed ID: 9441797
[TBL] [Abstract][Full Text] [Related]
15. Effects of a thromboxane receptor antagonist (NT-126) and a thromboxane synthase inhibitor (OKY-O46) on protamine-induced circulatory changes in dogs.
Mizutani T; Takahashi S; Kihara S; Toyooka H
J Cardiothorac Vasc Anesth; 2000 Dec; 14(6):687-92. PubMed ID: 11139110
[TBL] [Abstract][Full Text] [Related]
16. Protamine-heparin-induced pulmonary hypertension in pigs: effects of treatment with a thromboxane receptor antagonist on hemodynamics and coagulation.
Nuttall GA; Murray MJ; Bowie EJ
Anesthesiology; 1991 Jan; 74(1):138-45. PubMed ID: 1824742
[TBL] [Abstract][Full Text] [Related]
17. Heparin-protamine reactions in pigs: role of oxygen-derived free radicals.
Vollmar B; Conzen PF; Habazettl H; Yekebas E; Peter K
J Appl Physiol (1985); 1993 May; 74(5):2412-20. PubMed ID: 8335575
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of hemodynamic and hematologic effects of heparin-protamine sulfate interaction after aortic reconstruction in a canine model.
Wakefield TW; Lindblad B; Whitehouse WM; Hantler CB; Stanley JC
Surgery; 1986 Jul; 100(1):45-51. PubMed ID: 3726760
[TBL] [Abstract][Full Text] [Related]
19. Protamine-induced pulmonary venoconstriction in heparinized pigs.
Hakim TS; Picone A; Oleary CE; Camporesi EM
Anesth Analg; 1995 Jul; 81(1):38-43. PubMed ID: 7598279
[TBL] [Abstract][Full Text] [Related]
20. Role of platelet-activating factor in the ovine heparin-protamine reaction.
Montalescot G; Huerta JM; Braquet P; Zapol WM
J Appl Physiol (1985); 1992 Dec; 73(6):2604-7. PubMed ID: 1490976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]